This week, we have the pleasure to welcome Roberto Gradnik, President of the European Biopharmaceutical Enterprise Network, Former CEO of Stallergenes and VP of Merck Serono, in BioFIT 2016 conference programme.
Now CEO of Ixaltis, which freshly raised €8M in Series A last May, Mr. Gradnik will share his opinion alongside Thierry Laugel, Managing Partner of Kurma Partners, and Philippe Monteyne, VC Partner at Fund +, in a session entitled “How to spark the interest of VCs for Series A financing”?
Mr. Gradnik will share his experience and tell the BioFITers all about Series A, we can’t wait to see that !
You want to be a speaker at BioFIT 2016 ? Check out the programme and contact us!